Akili

By Laura Lovett June 7, 2018
A drug no longer needs to be a tangible object, according to panelist at the BIO 2018 convention in Boston. The way the pharma industry looks at medication is evolving and may be including new tech-focused treatments, such as digital therapeutics. “If you think about the trajectory of medicine what is a drug these days: is it a pill, is it an injection, is it infusion, is it gene therapy? We’ve...
By Dave Muoio May 9, 2018
This morning, Boston-based Akili Interactive Labs announced the closure of a $55 million Series C funding round. The investment was led by Temasek, with participation from Baillie Gifford, Amgen Ventures, M Ventures, JAZZ Venture Partners, Canepa Advanced Healthcare Fund, and Brooklands Capital Strategies. According to the company, this new funding will be used to support development, regulatory...
By Jonah Comstock June 28, 2017
PureTech Health subsidiary Akili Labs, which is working with pharma companies on health-oriented games like Project Evo, a video game for assessing and treating ADHD, has added some big names to its executive board. Former Cubist Pharmaceuticals CEO Robert J. Perez will move from advisor to executive chairman of Akili, while former DreamWorks Interactive CEO Glenn Entis, and former Chief Game...
By Aditi Pai January 9, 2014
Boston-based Akili Interactive Labs partnered with Pfizer to conduct a study of Akili's iOS-based game, Project Evo, in the hopes of using the game to detect indications of Alzheimer's in healthy individuals. The month-long study of 100 participants includes a mix of some who have risk markers of potentially developing Alzheimer's and some who do not. All participants will take the game home and...